Department of Medicine, University of California at San Diego School of Medicine, La Jolla, CA 92093, USA.
Proc Natl Acad Sci U S A. 2013 Apr 2;110(14):5510-5. doi: 10.1073/pnas.1303392110. Epub 2013 Mar 18.
Gα-interacting, vesicle-associated protein (GIV/Girdin) is a multidomain signal transducer that enhances PI3K-Akt signals downstream of both G-protein-coupled receptors and growth factor receptor tyrosine kinases during diverse biological processes and cancer metastasis. Mechanistically, GIV serves as a non-receptor guanine nucleotide exchange factor (GEF) that enhances PI3K signals by activating trimeric G proteins, Gαi1/2/3. Site-directed mutations in GIV's GEF motif disrupt its ability to bind or activate Gi and abrogate PI3K-Akt signals; however, nothing is known about how GIV's GEF function is regulated. Here we report that PKCθ, a novel protein kinase C, down-regulates GIV's GEF function by phosphorylating Ser(S)1689 located within GIV's GEF motif. We demonstrate that PKCθ specifically binds and phosphorylates GIV at S1689, and this phosphoevent abolishes GIV's ability to bind and activate Gαi. HeLa cells stably expressing the phosphomimetic mutant of GIV, GIV-S1689→D, are phenotypically identical to those expressing the GEF-deficient F1685A mutant: Actin stress fibers are decreased and cell migration is inhibited whereas cell proliferation is triggered, and Akt (a.k.a. protein kinase B, PKB) activation is impaired downstream of both the lysophosphatidic acid receptor, a G-protein-coupled receptor, and the insulin receptor, a receptor tyrosine kinase. These findings indicate that phosphorylation of GIV by PKCθ inhibits GIV's GEF function and generates a unique negative feedback loop for downregulating the GIV-Gi axis of prometastatic signaling downstream of multiple ligand-activated receptors. This phosphoevent constitutes the only regulatory pathway described for terminating signaling by any of the growing family of nonreceptor GEFs that modulate G-protein activity.
G 蛋白相互作用、囊泡相关蛋白(GIV/Girdin)是一种多功能信号转导蛋白,可增强多种生物过程和癌症转移中 G 蛋白偶联受体和生长因子受体酪氨酸激酶下游的 PI3K-Akt 信号。在机制上,GIV 作为一种非受体鸟嘌呤核苷酸交换因子(GEF),通过激活三聚体 G 蛋白 Gαi1/2/3 增强 PI3K 信号。GIV 的 GEF 基序中的定点突变会破坏其与 Gi 结合或激活的能力,并消除 PI3K-Akt 信号;然而,目前尚不清楚 GIV 的 GEF 功能如何受到调节。在这里,我们报告一种新型蛋白激酶 C(PKCθ)通过磷酸化 GIV 的 GEF 基序内的丝氨酸(Ser)1689 下调 GIV 的 GEF 功能。我们证明 PKCθ 特异性结合并磷酸化 GIV 的 S1689,该磷酸化事件会消除 GIV 与 Gαi 结合和激活的能力。稳定表达 GIV 磷酸模拟突变体 GIV-S1689→D 的 HeLa 细胞与表达 GEF 缺陷 F1685A 突变体的细胞表型完全相同:肌动蛋白应力纤维减少,细胞迁移受到抑制,而细胞增殖被触发,并且 Akt(也称为蛋白激酶 B,PKB)的激活受到损害下游的溶血磷脂酸受体,一种 G 蛋白偶联受体,和胰岛素受体,一种受体酪氨酸激酶。这些发现表明 PKCθ 对 GIV 的磷酸化抑制了 GIV 的 GEF 功能,并为下游多种配体激活受体的促转移信号的 GIV-Gi 轴的下调生成了一个独特的负反馈回路。该磷酸化事件构成了描述用于终止任何调节 G 蛋白活性的非受体 GEF 家族不断增长的信号的唯一调节途径。